Triage UltraSound in Tb Endemic Regions

NCT05423847 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 504

Last updated 2025-02-13

No results posted yet for this study

Summary

In Sub-Saharan Africa, lower respiratory tract infections (LRTIs) and tuberculosis (TB) jointly are the leading cause of overall mortality. There is a need to integrate sustainable triage and management strategies into standard care. The TrUST study investigates the utility of point-of-care ultrasound (POCUS) for diagnosis and prognosis of LRTIs in TB endemic regions in the outpatient triage setting. Automated interpretation of POCUS by artificial intelligence (AI) may further standardize and improve its predictive utility as well as facilitate its implementation into usual practice.

Conditions

Interventions

DIAGNOSTIC_TEST

POCUS

POCUS of lungs, pericardium and abdomen

Sponsors & Collaborators

  • National University Hospital for tuberculosis, Cotonou, Benin

    collaborator UNKNOWN
  • Ecole Polytechnique Fédérale de Lausanne

    collaborator OTHER
  • University of Witwatersrand, South Africa

    collaborator OTHER
  • National University Hospital (CNHU point G), Bamako, Mali

    collaborator UNKNOWN
  • Centre Hospitalier Universitaire Vaudois

    lead OTHER

Principal Investigators

  • Mary-Anne Hartley, MD-PhD · Ecole Polytechnique Fédérale de Lausanne

  • Noémie Boillat Blanco, MD-PhD · University of Lausanne Hospitals

  • Veronique Suttels, MD · University of Lausanne Hospitals

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-10-14
Primary Completion
2023-08-11
Completion
2025-02-10
FDA Device
Yes

Countries

  • Benin
  • Mali
  • South Africa

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05423847 on ClinicalTrials.gov